We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Battery-Less Neurostimulator Treats Overactive Bladder

By HospiMedica International staff writers
Posted on 27 Jun 2016
Print article
Image: The new neurostimulation device is designed to treat an overactive bladder (Photo courtesy of UGNM).
Image: The new neurostimulation device is designed to treat an overactive bladder (Photo courtesy of UGNM).
A miniature wireless neurostimulation device could help improve the quality of life for patients with overactive bladder (OAB).

The Bluewind Medical OAB-1000 is a wireless, battery-less neurostimulator, which is 90% smaller than current typical neurostimulators, allowing physicians to treat OAB with a minimally invasive simple surgical procedure that places it near the tibial nerve, in the lower leg. The device electrically stimulates the tibial nerve, which influences urinary function, and is powered wirelessly by an external control unit worn by the patient for only 30 minutes which can also be used while performing daily tasks without interruption.

“Today, neurostimulators that treat OAB are large, bulky, and require complex and expensive surgery. BlueWind's implantable microstimulators are significantly smaller, allow for a simple implant procedure, and are easier for patients to use at home,” said Guri Oron, CEO of Bluewind, a company of Rainbow Medical (Herzeliya Pituach, Israel). “This is the first product out of many in our pipeline that will transform neurostimulation and by that, will enable the treatment of millions of additional patients.”

“The device was easy to implant, activate and use. European participants in the study liked the idea of such a small implant and a very short procedure,” said Sohier Elneil, MD, of University College London (UCL; UK) and the National Hospital for Neurology and Neurosurgery (NHNN; London, UK). “They were very favorable to having the flexibility and sense of control by treating themselves at home. The patients were also relieved from the burden of logistics associated with therapy in the clinic.”

Percutaneous neuromodulation (PTNM) works by delivering a gentle electrical pulse to the tibial nerve in the skin near the ankle via a neurostimulator. The electrical stimulation is thought to indirectly activate the central nervous system (CNS) to help alleviate OAB symptoms such as urinary frequency, urinary incontinence, and urge incontinence episodes.

Related Links:
Rainbow Medical
National Hospital for Neurology and Neurosurgery
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.